相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer
John M. Seligson et al.
ANNALS OF PHARMACOTHERAPY (2021)
Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions
Minru Liao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Triple-negative breast cancer: A run-through of features, classification and current therapies
Meghana Manjunath et al.
ONCOLOGY LETTERS (2021)
Discovery of 5,6-Bis(4-methoxy-3-methylphenyl)pyridin-2-amine as a WSB1 Degrader to Inhibit Cancer Cell Metastasis
Jinxin Che et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer
Ting Li et al.
CELL DEATH & DISEASE (2021)
Annexin A3, a Calcium-Dependent Phospholipid-Binding Protein: Implication in Cancer
Liu Yang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Advancing targeted protein degradation for cancer therapy
Brandon Dale et al.
NATURE REVIEWS CANCER (2021)
Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications
Saimul Islam et al.
CELLULAR ONCOLOGY (2020)
ANXA4 Activates JAK-STAT3 Signaling by Interacting with ANXA1 in Basal-Like Breast Cancer
Lei Li et al.
DNA AND CELL BIOLOGY (2020)
Pharmacotherapeutic options for patients with refractory breast cancer
Palma Fedele et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells
Bai Cui et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
Triple-negative (TNBC) metastatic breast cancer (MBC) patients (pts): Is chemotherapy (CHT) choice influenced by adjuvant (adj) treatments? Results from the GIM-13 AMBRA study.
Giorgio Mustacchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Ubiquitylation at the crossroads of development and disease
Michael Rape
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer
Ju-Yeon Kim et al.
CLINICAL BREAST CANCER (2018)
Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer
Ruikai Du et al.
CELL DEATH & DISEASE (2018)
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Jennifer K. Litton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The regulatory role of Annexin 3 in a nude mouse bearing a subcutaneous xenograft of MDA-MB-231 human breast carcinoma
Jie Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
miR-221/222 activate the Wnt/beta-catenin signaling to promote triple-negative breast cancer
Sanhong Liu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2018)
Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells
Tao Zhou et al.
ONCOLOGY REPORTS (2017)
Dimericbiscognienyne A: A Meroterpenoid Dimer from Biscogniauxia sp with New Skeleton and Its Activity
Huan Zhao et al.
ORGANIC LETTERS (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Weekly Paclitaxel, Capecitabine, and Bevacizumab With Maintenance Capecitabine and Bevacizumab as First-Line Therapy for Triple-Negative, Metastatic, or Locally Advanced Breast Cancer: Results From the GINECO A-TaXel Phase 2 Study
Jean-Marc Ferrero et al.
CANCER (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Polycycloiridals A-D, Four Iridal-Type Triterpenoids with an α-Terpineol Moiety from Iris tectorum
Chun-Lei Zhang et al.
ORGANIC LETTERS (2015)
The role of annexin A3 playing in cancers
Na Wu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
The wnt/beta-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
Taj D. King et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Triple-Negative Breast Cancer: An Unmet Medical Need
Clifford A. Hudis et al.
ONCOLOGIST (2011)
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Andrey I. Khramtsov et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Probing the Probes: Fitness Factors For Small Molecule Tools
Paul Workman et al.
CHEMISTRY & BIOLOGY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The role of annexins in tumour development and progression
S. Mussunoor et al.
JOURNAL OF PATHOLOGY (2008)
Drug discovery in the ubiquitin-proteasome system
Grzegorz Nalepa et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Annexins:: Linking Ca2+ signalling to membrane dynamics
V Gerke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Protein-reactive natural products
C Drahl et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)